• Point/Counterpoint: Stenting for idiopathic intracranial hypertension

  • Aug 16 2023
  • Duración: 32 m
  • Podcast

Point/Counterpoint: Stenting for idiopathic intracranial hypertension

  • Resumen

  • In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, speaks with Dr. Michael Levitt (1) and Dr. Colin Derdeyn (2), authors of a pair of editorials discussing the practice of dural venous sinus stenting for patients with idiopathic intracranial hypertension.

    Point: Dural venous sinus stenting should be considered a first-line treatment option for select patients with idiopathic intracranial hypertension https://jnis.bmj.com/content/early/2023/06/20/jnis-2023-020597

    Counterpoint: stenting for idiopathic intracranial hypertension should be trialed https://jnis.bmj.com/content/early/2023/06/20/jnis-2023-020404

    These articles are free-to-access for a month following the publication of this podcast.

    Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767

    Thank you for listening! This episode was edited by Brian O'Toole.

    (1) Neurological Surgery, University of Washington School of Medicine, Seattle, Washington, USA (2) Radiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA

    Más Menos
activate_Holiday_promo_in_buybox_DT_T2

Lo que los oyentes dicen sobre Point/Counterpoint: Stenting for idiopathic intracranial hypertension

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.